788 related articles for article (PubMed ID: 15516696)
61. Effect of dual blockade of the renin-angiotensin system on the progression of type 2 diabetic nephropathy: a randomized trial.
Fernandez Juarez G; Luño J; Barrio V; de Vinuesa SG; Praga M; Goicoechea M; Cachofeiro V; Nieto J; Fernández Vega F; Tato A; Gutierrez E;
Am J Kidney Dis; 2013 Feb; 61(2):211-8. PubMed ID: 22939518
[TBL] [Abstract][Full Text] [Related]
62. Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy: A Randomized Clinical Trial.
Bakris GL; Agarwal R; Chan JC; Cooper ME; Gansevoort RT; Haller H; Remuzzi G; Rossing P; Schmieder RE; Nowack C; Kolkhof P; Joseph A; Pieper A; Kimmeskamp-Kirschbaum N; Ruilope LM;
JAMA; 2015 Sep; 314(9):884-94. PubMed ID: 26325557
[TBL] [Abstract][Full Text] [Related]
63. Telmisartan in incipient and overt diabetic renal disease.
Schmieder RE; Bakris G; Weir MR
J Nephrol; 2011; 24(3):263-73. PubMed ID: 21374585
[TBL] [Abstract][Full Text] [Related]
64. Telmisartan vs. enalapril in type 2 diabetes.
Asgari AA; Sarvghadi F; Zahed N
N Engl J Med; 2005 Feb; 352(8):835-6; author reply 835-6. PubMed ID: 15728820
[No Abstract] [Full Text] [Related]
65. Residual proteinuria and eGFR predict progression of renal impairment within 2 years in type 2 diabetic patients with nephropathy who are receiving optimal treatment with angiotensin receptor blockers.
Ivory SE; Packham DK; Reutens AT; Wolfe R; Rohde RD; Lewis J; Atkins RC;
Nephrology (Carlton); 2013 Jul; 18(7):516-24. PubMed ID: 23506627
[TBL] [Abstract][Full Text] [Related]
66. A pilot study on the effect of telmisartan & ramipril on 24 h blood pressure profile & dipping pattern in type 1 diabetes patients with nephropathy.
Anantharaman R; Bhansali A; Bhadada SK; Kohli HS; Walia R; Shanmugasundar G; Jayaprakash P
Indian J Med Res; 2011 Nov; 134(5):658-63. PubMed ID: 22199105
[TBL] [Abstract][Full Text] [Related]
67. Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients.
Ravid M; Savin H; Jutrin I; Bental T; Katz B; Lishner M
Ann Intern Med; 1993 Apr; 118(8):577-81. PubMed ID: 8452322
[TBL] [Abstract][Full Text] [Related]
68. Impact of telmisartan versus ramipril on renal endothelial function in patients with hypertension and type 2 diabetes.
Schmieder RE; Delles C; Mimran A; Fauvel JP; Ruilope LM
Diabetes Care; 2007 Jun; 30(6):1351-6. PubMed ID: 17337492
[TBL] [Abstract][Full Text] [Related]
69. Dual blockade of the renin-angiotensin system in diabetic nephropathy: a randomized double-blind crossover study.
Rossing K; Christensen PK; Jensen BR; Parving HH
Diabetes Care; 2002 Jan; 25(1):95-100. PubMed ID: 11772908
[TBL] [Abstract][Full Text] [Related]
70. [New effects of telmisartan, an angiotensin 2 receptor blocker, in the treatment of arterial hypertension with metabolic disorders].
Demin AA; Shuliat'eva OIu
Klin Med (Mosk); 2012; 90(1):32-4. PubMed ID: 22567936
[TBL] [Abstract][Full Text] [Related]
71. Long-term effects of addition of mineralocorticoid receptor antagonist to angiotensin II receptor blocker in patients with diabetic nephropathy: a randomized clinical trial.
Esteghamati A; Noshad S; Jarrah S; Mousavizadeh M; Khoee SH; Nakhjavani M
Nephrol Dial Transplant; 2013 Nov; 28(11):2823-33. PubMed ID: 24009294
[TBL] [Abstract][Full Text] [Related]
72. A five-year comparison of the renal protective effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with non-diabetic nephropathy.
Shoda J; Kanno Y; Suzuki H
Intern Med; 2006; 45(4):193-8. PubMed ID: 16543688
[TBL] [Abstract][Full Text] [Related]
73. Angiotensin-converting enzyme inhibition in nondiabetic progressive renal insufficiency: a controlled double-blind trial.
Ihle BU; Whitworth JA; Shahinfar S; Cnaan A; Kincaid-Smith PS; Becker GJ
Am J Kidney Dis; 1996 Apr; 27(4):489-95. PubMed ID: 8678058
[TBL] [Abstract][Full Text] [Related]
74. Renal and retinal effects of enalapril and losartan in type 1 diabetes.
Mauer M; Zinman B; Gardiner R; Suissa S; Sinaiko A; Strand T; Drummond K; Donnelly S; Goodyer P; Gubler MC; Klein R
N Engl J Med; 2009 Jul; 361(1):40-51. PubMed ID: 19571282
[TBL] [Abstract][Full Text] [Related]
75. Changes in urinary albumin excretion, inflammatory and oxidative stress markers in ADPKD patients with hypertension.
Nakamura T; Sato E; Fujiwara N; Kawagoe Y; Yamada S; Ueda Y; Koide H
Am J Med Sci; 2012 Jan; 343(1):46-51. PubMed ID: 21760473
[TBL] [Abstract][Full Text] [Related]
76. Effect of telmisartan on renal outcomes: a randomized trial.
Mann JF; Schmieder RE; Dyal L; McQueen MJ; Schumacher H; Pogue J; Wang X; Probstfield JL; Avezum A; Cardona-Munoz E; Dagenais GR; Diaz R; Fodor G; Maillon JM; Rydén L; Yu CM; Teo KK; Yusuf S;
Ann Intern Med; 2009 Jul; 151(1):1-10, W1-2. PubMed ID: 19451556
[TBL] [Abstract][Full Text] [Related]
77. Telmisartan vs. enalapril in type 2 diabetes.
Parving HH; Hovind P; Rossing P
N Engl J Med; 2005 Feb; 352(8):835-6; author reply 835-6. PubMed ID: 15736292
[No Abstract] [Full Text] [Related]
78. Blood pressure in early autosomal dominant polycystic kidney disease.
Schrier RW; Abebe KZ; Perrone RD; Torres VE; Braun WE; Steinman TI; Winklhofer FT; Brosnahan G; Czarnecki PG; Hogan MC; Miskulin DC; Rahbari-Oskoui FF; Grantham JJ; Harris PC; Flessner MF; Bae KT; Moore CG; Chapman AB;
N Engl J Med; 2014 Dec; 371(24):2255-66. PubMed ID: 25399733
[TBL] [Abstract][Full Text] [Related]
79. A randomized, double-blind, placebo-controlled trial to evaluate the effect of enalapril in patients with clinical diabetic nephropathy.
Bauer JH; Reams GP; Hewett J; Klachko D; Lau A; Messina C; Knaus V
Am J Kidney Dis; 1992 Nov; 20(5):443-57. PubMed ID: 1442757
[TBL] [Abstract][Full Text] [Related]
80. Combined angiotensin inhibition for the treatment of diabetic nephropathy.
Fried LF; Emanuele N; Zhang JH; Brophy M; Conner TA; Duckworth W; Leehey DJ; McCullough PA; O'Connor T; Palevsky PM; Reilly RF; Seliger SL; Warren SR; Watnick S; Peduzzi P; Guarino P;
N Engl J Med; 2013 Nov; 369(20):1892-903. PubMed ID: 24206457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
